How Big Insider Trading Can Impact Boston Scientific Corporation (NYSE:BSX) Stock?

Boston Scientific Corporation (NYSE:BSX) exchanged hands 6,655,800 shares versus average trading capacity of 8.57M shares, while its relative trading volume is 0.77. Boston Scientific Corporation (NYSE:BSX)’s total market worth is $34.03B along with 1.36B outstanding shares.

Insiders has most recently took part in a trading activity, Pierce David A, SVP and President, Endoscopy of the company in a transaction that occurred 3/3/2017 sold 25,012 shares of the stock. The stock was sold at a price of $25.01, for a total value of $625,668. Subsequent to the transaction Pierce David A owned a total of 25,600 shares of the stock.

In a separate transaction on 3/3/2017, Pratt Timothy A., EVP, CG & Chief Admin Officer sold 23,540 shares of the stock. The stock was sold at a price of $23,540, for a total worth of $588,846. Succeeding to the transaction Pratt Timothy A. owned overall 245,846 shares of the stock.

Moreover, Mackey Edward F, EVP, Operations sold 6,239 shares of the stock in a reserved transaction that ensued on 3/2/2017. At a price of $25.00, the stock was sold for an entire value of $155,975. Consequent to the transaction Mackey Edward F owned a total of 30,819 shares of the stock.

Currently, 0.20% shares of Boston Scientific Corporation (NYSE:BSX) are owned by insiders with -10.86% six-month change in the insider ownership. The insider filler data counts the number of monthly positions over 3 month and 12 month time spans. For Boston Scientific Corporation (NYSE:BSX) total 107 number of trades held during last 3 months and 154 during last 12 months, out of them 12 numbers of buys held in last 3 months and 22 buys in last 12 months. Whereas 95 numbers of sells held in last 3 months and 132 sells over the past 12 months.

For the duration of last three months Boston Scientific Corporation (NYSE:BSX)’s total number of shares bought are 661,300 and sold 782,239 from a total of 1,443,539 traded shares. During last twelve months 730,110 number of shares bought and 2,280,942 sold from a total of 3,011,052 shares traded. A net activity of 120,939 took place in the course of three months, while 1,550,832 during last twelve months. Insider trading information is derived from Forms 3 and 4 filings are filed with the U.S. Securities and Exchange Commission (SEC).

Boston Scientific Corporation (NYSE:BSX) ended last trading session at the price of $24.98 whereas a number of traders indicating mean target price will hit $28.07 over the next twelve months, mean value of price target most recently revised on 02/27/17. Boston Scientific Corporation (NYSE:BSX)’s highest estimates of price target are $30.00 and low forecast is $24.00 based on the opinion of 21 analysts. The price target estimates represents a standard deviation of 1.77. However brokerage recommendations suggests an ABR of 1.63 based on calls of 20 experts.

Boston Scientific Corporation (NYSE:BSX) is expected to release the earnings of its current quarter on 4/26/17. The company is expected to release $0.3 EPS during current quarter according to 23 analysts whereas the company reported $0.28 EPS during same quarter a year ago. For the current quarter the stock has a lowest EPS estimates of $0.29 and high estimate of $0.31. Boston Scientific Corporation (NYSE:BSX)’s average revenue estimates for the current quarter are $2.08B according to 20 number of analysts. However its lowest revenue estimates are $2.07B and highest revenue estimates are $2.1B. A year ago the company’s sales were $1.96B. Its yearly sales growth estimates are 6.00%. Past 5 years growth of Boston Scientific Corporation (NYSE:BSX) observed at 31.52%, and for the next five years the analysts that follow this company are expecting its growth at 12.45%.

Analyst’s Activity to Watch: Boston Scientific Corporation (NYSE:BSX)

Boston Scientific Corporation (NYSE:BSX) plunged -1.05% during previous trade, a total of 8.46M shares exchanged hands compared with its average trading volume of 9.55M shares whereas its relative volume is 0.96. The stock has a market capitalization of $33.51B along with 1.36B outstanding shares. Stock’s intraday price range hit the peak level of $24.78 and touched the lowest level of $24.54.

Most recently Boston Scientific Corporation (NYSE:BSX)’s price target was revised on 02/27/17 and according to 21 analysts stock’s price will reach at $28.12 during 52 weeks with standard deviation of 1.77. Stock’s minimum price target estimates has been figured out at $24 while the maximum price target forecast is established at $30, if we look at the price target with an optimistic approach it has upside potential of 22% from its latest closing price of $24.55.

Historically, if we look at price target revisions, three weeks ago Boston Scientific Corporation (NYSE:BSX)’s price target was revised on 02/03/17 by the analysts, however the bullish price estimates of the stock set at $30 while the bearish estimates kept at $24 over the next one year. Stock’s 52-week target was retained at $27.47, the estimates indicates a standard deviation of 1.77.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 1.63. ABR value is precisely based on brokerage recommendations, where out of 20 brokerage recommendations 12 rate Boston Scientific Corporation (NYSE:BSX) stock a Strong Buy, 3 rate the stocks of the company a Buy, 5 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 9/1/2016 the stock of Boston Scientific Corporation (NYSE:BSX) upgraded by Argus from Hold to Buy. However previously on 10/5/15 it was upgraded by Raymond James from Outperform to Strong Buy. A research note issued on 9/28/15 the stock was upgraded by Needham from Hold to Buy.

Boston Scientific Corporation (NYSE:BSX) performance over the past one year soared 44.58% whereas its year to date (YTD) performance indicated a bullish trend of 13.50%. During the last six months the stock climbed 2.42%. Quarterly performance of the company shows optimistic momentum of 16.08% while its last one month trend is positive with 2.85%. Stock’s weekly performance expressed down trend of -2.89%.

The company’s price sits 4.35% above from its 50-day moving average of $24.47 and 6.46% far from the stock’s 200-day moving average which is $23. Boston Scientific Corporation (NYSE:BSX)’s shares are currently trading -4.29% away from the 52-week high price of $25.65 and +45.96% far from the 52-week low price of $16.82.

According to consensus agreement of 23 analysts Boston Scientific Corporation (NYSE:BSX) will report earnings per share of $0.3 in their quarterly report and it is expected to announce the company’s results on 4/26/17. For the current quarter the company has high EPS estimates of $0.31 in contradiction of low EPS estimates of $0.29. However a year ago for the same quarter the company has reported $0.28 EPS. Current year EPS projections for Boston Scientific Corporation (NYSE:BSX) set at $1.25 according to the sentiments of 24 analysts, while its lowest earnings estimates are $1.22 and highest earnings estimates are $1.27.

According to 20 analysts, Boston Scientific Corporation (NYSE:BSX)’s revenue estimates for the current quarter are $2.08B meanwhile the company has high revenue estimates of $2.1B in contradiction of low revenue estimates of $2.07B. For the current year the company’s revenue estimates are $8.78B compared to low analyst estimates of $8.42B and high estimates of $9.06B according to the projection of 23 analysts.

Overbuying Activity: Boston Scientific Corporation (NYSE:BSX)

Boston Scientific Corporation (NYSE:BSX) share price soared 0.36% or +0.09 points to reach at $25.23 during previous trading session. The stock’s price fluctuated within the range of $25.06 – $25.38 during previous trading session. A total of 6,865,900 shares exchanged hands, whereas the company’s average trading volume stands at 8.54M shares. Boston Scientific Corporation (NYSE:BSX) has a market capitalization of $34.25B and most recently 1.36B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Boston Scientific Corporation (NYSE:BSX) is at 80.58.

According to sentiments of 21 analysts the mean estimates of short term price target for the company’s stock is marked at $28.12. The most optimistic analyst sees the stock reaching $30.00 while the most conventional predicts the target price at $24.00.

The consensus mean EPS for the current quarter is at $0.3 derived from a total of 23 estimates. According to analysts minimum EPS for the current quarter is expected at $0.29 and can go high up to $0.29. However a year ago during same quarter Boston Scientific Corporation (NYSE:BSX) reported $0.28 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.31 per share according to consensus of 23 analysts.

According to sentiments of 20 analysts the company is expected to report revenues of $2.08B for the current quarter. Bearish revenue estimates established at $2.06B while the bullish revenue forecast has been figured out at $2.1B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 1.80 on the shares of Boston Scientific Corporation (NYSE:BSX). Out of rating recommendations 10 have given the stock a Buy while 10 recommend the stock as Outperform. 5 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Boston Scientific Corporation (NYSE:BSX)’s distance from 20 day simple moving average is 5.68% whereas its distance from 50 day simple moving average is 5.68% along with 10.65% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Boston Scientific Corporation (NYSE:BSX) shares were trading -0.12% below from the 52-week high mark of $25.26 and +61.01% above from the 52-week bottom of $15.67. The stock hit its 52-week high price on 02/07/17, and 52-week low price on 02/12/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 4.86% in the past one week and soared 13.91% during previous one month drive, the stock went up 17.02% during past quarter. In the last six months the stock’s performance soared 5.65% while yearly performance of the company advanced 57.00%. The company’s year to date (YTD) performance is at 16.64%.

While taking a glance at financials, we can look at a number of key indicators. Boston Scientific Corporation (NYSE:BSX) has a Return on Assets (ROA) of 1.90%. The company currently has a Return on Equity (ROE) of 5.40% and a Return on Investment (ROI) of 5.10%. Average true range (ATR-14) of the company sets at 0.43, along with its weekly and monthly volatility of 1.95%, 1.89% respectively. Beta value of the stock stands at 1.08.

The company’s quick ratio for most recent quarter is 0.60 along with current ratio for most recent quarter of 0.90. Total debt to equity ratio of the company for most recent quarter is 0.81 whereas long term debt to equity ratio for most recent quarter is 0.80.

Stock to Watch for Earnings: Boston Scientific Corporation (NYSE:BSX)

Shares of Boston Scientific Corporation (NYSE:BSX) jumped 0.44% to reach at $25.22 during previous trading session. The company has experienced volume of 10,992,000 shares while on average the company has a capacity of trading 8.57M share.

Boston Scientific Corporation (NYSE:BSX) on February 2, 2017 generated sales of $2.191 billion during the fourth quarter ended December 31, 2016. This represents growth of 11 percent compared to the prior year period on a reported and operational basis (calculated on constant currency basis). The company reported GAAP earnings of $124 million or $0.09 per share (EPS), compared to a GAAP loss of $142 million or $(0.11) per share a year ago, and achieved adjusted earnings per share of $0.30 for the period, compared to $0.26 a year ago.

For the year ended December 31, 2016, the company achieved full year sales of $8.386 billion, representing 12 percent revenue growth on a reported and operational basis. The company reported GAAP earnings of $0.25 per share, compared to a GAAP loss of $(0.18) in the prior year period and delivered full year adjusted earnings per share of $1.11, compared to $0.93 in 2015.

Boston Scientific Corporation (NYSE:BSX) holds the market capitalization of $34.51B along with 1.36B outstanding shares. During the last trade, stock’s minimum price has been reached out at $24.80 while the maximum trading price moved at $25.26. Currently the stock price is moving -0.08% off from the highest level of twelve months and +60.94% above from twelve months low. Boston Scientific Corporation (NYSE:BSX) marked 52-week highest price level of $25.24 on 02/03/17 and 52-week lowest price level of $15.67 on 02/08/16. For the stock, price target value has been calculated at $28.17 based on calls of 21 experts. Stock’s minimum price target estimates has been figured out at $24.00 while the maximum price target forecast is established at $30.00.

As of current trade, Boston Scientific Corporation (NYSE:BSX) has shown weekly upbeat performance of 5.66%. Its six months performance indicated a bullish movement while its yearly performance reflected a positive trend of 45.44%. Year-to-date (YTD) performance of the stock illustrate upbeat trend of 16.60%. Shares of Boston Scientific Corporation (NYSE:BSX) currently have an ABR of 1.83, derived from a total of 12 opinions. The company’s price sits 13.95% above from its 50-day moving average of $22.97 and 10.88% above from the stock’s 200-day moving average of $22.88. The company has Relative Strength Index (RSI 14) of 81.44 along with Average True Range (ATR 14) of 0.44. Its weekly and monthly volatility is 2.02%, 1.86% respectively. The company’s beta value is at 1.08.

Boston Scientific Corporation (NYSE:BSX) currently has a PEG ratio of 8.05 where as its P/E ratio is 100.08. The company’s price to sales ratio for trailing twelve months is 4.08 and price to book ratio for most recent quarter is 5.11, whereas price to cash per share for the most recent quarter is 174.38. Boston Scientific Corporation (NYSE:BSX)’s quick ratio for most recent quarter is 0.60 along with current ratio for most recent quarter of 0.90. Total debt to equity ratio of the company for most recent quarter is 0.81 whereas long term debt to equity ratio for most recent quarter is 0.80. Boston Scientific Corporation (NYSE:BSX) has a Return on Assets of 1.90%. The company currently has a Return on Equity of 5.40% and Return on Investment of 5.10%.

Estimations under Considerations: Boston Scientific Corporation (NYSE:BSX)

Boston Scientific Corporation (NYSE:BSX) plunged -0.42% or -0.10 points during previous trade after opening at the price of $24.00, a total of 13,128,900 shares exchanged hands compared with its average trading volume of 8.33M shares. The stock has a market capitalization of $32.91B and it has 1.36B outstanding shares.

According to consensus agreement of 24 analysts Boston Scientific Corporation (NYSE:BSX) will report earnings per share of $0.29 in their quarterly report and it is expected to announce the company’s results on 2/2/17 Before Market Open. The stock added almost 7.2% in price since last earning report, when its share price was $22.44. For the current quarter the company has highest EPS estimates of $0.3 and low forecast is $0.28. However a year ago for the same quarter the company has reported $0.26 earnings per share.

Earnings reaction history indicates that share price went up 14 times out of last 28 quarters. In Boston Scientific Corporation (NYSE:BSX)’s last 12 earnings reports, it has beaten EPS estimates 66% of the time. However it has meet the estimates 4 times and missed 0 time.

If we have a peek on EPS and surprise factor history during last four quarters, for the previous quarter ended on 9/2016, the consensus mean EPS was $0.27 while Boston Scientific Corporation (NYSE:BSX) reported $0.27 EPS on 10/26/2016 Before Market Open with no difference marking a surprise factor of 0.00%. The stock’s next day closing price was $22.09 with the loss of -1.56% in its share price. On seventh day of the earnings report price change of the stock was -3.25%.

Previously for the quarter ended on 6/2016, Boston Scientific Corporation (NYSE:BSX)’s expected mean EPS was $0.27, the company reported its quarterly earnings per share of $0.27 on 7/28/2016 Before Market Open, meeting the analysts’ consensus estimate by 0.00 with surprise factor of 0.00%. The stock’s closing price was $24.34 with the gain of 2.87% in its share price on the day following the earning announcement. However price change of the stock was 0.76% on seventh day of the earnings report.

Boston Scientific Corporation (NYSE:BSX)’s mean EPS estimate was $0.24 for the quarter ended on 3/2016, while it reported EPS of $0.28 on 4/27/2016 Before Market Open, beating the analysts’ consensus estimate by 0.04 with surprise factor of 16.67%. On next day when data was publically announced, the stock’s closing price was $21.89 with 11.17% gain in its share price. On seventh day of the earnings report price change of the stock was up 10.61%.

Back on 2/4/2016 the company’s estimated EPS value was $0.25 and it reported $0.26 earnings per share (EPS) for the quarter ended on 12/2015. The company posted a positive surprise factor of 4.00% by 0.01.

Average EPS forecast for the current year is $1.1 according to 26 analysts making projections for Boston Scientific Corporation (NYSE:BSX). The most expectant earnings per share estimate of the stock is set at $1.12 while the conservative estimates kept at $1.09 over the current year. Having a look at the historical EPS report, the company attained $0.93 EPS for the previous year. While revenue estimates for the current year is $8.35B, Boston Scientific Corporation (NYSE:BSX) setting the highest revenues estimates of $8.38B and indicating lowest revenues at $8.34B according to agreement of 24 number of analysts. Current quarter revenue movements show that, the company has set average revenue estimates of $2.16B covering forecast of 21 analysts. The company indicates a peak revenue level of $2.19B and $2.14B at bottom level.

Having a glance at growth estimates of the company, it has current quarter growth estimates of 11.50% whereas for next quarter it has 3.60% estimations over growth. Its forecasts over growth are 18.30% during current year while analysts’ growth estimation for the next year is 13.60%. Past 5 years growth of Boston Scientific Corporation (NYSE:BSX) observed at 30.57%, and for the next five years the analysts that follow this company are expecting its growth at 12.44%.

Boston Scientific Corporation (NYSE:BSX) reached at $23.96 price level during last trade its distance from 20 days simple moving average is 2.79%, and its distance from 50 days simple moving average is 8.86% while it has a distance of 5.57% from the 200 days simple moving average. One year trading price range hit the peak level of $24.79 and touched the lowest level of $15.67. The company’s distance from 52-week high price is -3.35% and current price is above +52.90% from 52-week low price.

Analysts Recommendation and Price Reaction History on: Boston Scientific Corporation (NYSE:BSX)

Boston Scientific Corporation (NYSE:BSX) plunged -0.68% during previous trade, a total of 4.72M shares exchanged hands compared with its average trading volume of 7.50M shares whereas its relative volume is 0.53. The stock has a market capitalization of $31.94B along with 1.36B outstanding shares. Stock’s intraday price range hit the peak level of $23.68 and touched the lowest level of $23.39.

Most recently Boston Scientific Corporation (NYSE:BSX)’s price target was revised on 01/10/17 and according to 21 analysts stock’s price will reach at $27.38 during 52 weeks with standard deviation of 2.53. Stock’s minimum price target estimates has been figured out at $24 while the maximum price target forecast is established at $30, if we look at the price target with an optimistic approach it has upside potential of 27% from its latest closing price of $23.42.

Historically, if we look at price target revisions, three weeks ago Boston Scientific Corporation (NYSE:BSX)’s price target was revised on 01/03/17 by the analysts, however the bullish price estimates of the stock set at $30 while the bearish estimates kept at $19.50 over the next one year. Stock’s 52-week target was retained at $26.64, the estimates indicates a standard deviation of 2.53.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 1.57. ABR value is precisely based on brokerage recommendations, where out of 22 brokerage recommendations 14 rate Boston Scientific Corporation (NYSE:BSX) stock a Strong Buy, 3 rate the stocks of the company a Buy, 5 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 9/1/2016 the stock of Boston Scientific Corporation (NYSE:BSX) upgraded by Argus from Hold to Buy. However previously on 10/5/15 it was upgraded by Raymond James from Outperform to Strong Buy. A research note issued on 9/28/15 the stock was upgraded by Needham from Hold to Buy.

Boston Scientific Corporation (NYSE:BSX) performance over the past one year soared 36% whereas its year to date (YTD) performance indicated a bullish trend of 8.28%. During the last six months the stock slipped -1.01%. Quarterly performance of the company shows optimistic momentum of 4.37% while its last one month trend is positive with 7.38%. Stock’s weekly performance expressed down trend of -1.93%.

The company’s price sits 7.42% above from its 50-day moving average of $22.24 and 3.58% far from the stock’s 200-day moving average which is $22.86. Boston Scientific Corporation (NYSE:BSX)’s shares are currently trading -5.53% away from the 52-week high price of $24.79 and +49.46% far from the 52-week low price of $15.67.

According to consensus agreement of 24 analysts Boston Scientific Corporation (NYSE:BSX) will report earnings per share of $0.29 in their quarterly report and it is expected to announce the company’s results on 2/2/17 Before Market Open. For the current quarter the company has high EPS estimates of $0.3 in contradiction of low EPS estimates of $0.28. However a year ago for the same quarter the company has reported $0.26 EPS. Current year EPS projections for Boston Scientific Corporation (NYSE:BSX) set at $1.1 according to the sentiments of 26 analysts, while its lowest earnings estimates are $1.09 and highest earnings estimates are $1.12.

According to 21 analysts, Boston Scientific Corporation (NYSE:BSX)’s revenue estimates for the current quarter are $2.16B meanwhile the company has high revenue estimates of $2.19B in contradiction of low revenue estimates of $2.14B. For the current year the company’s revenue estimates are $8.35B compared to low analyst estimates of $8.34B and high estimates of $8.38B according to the projection of 24 analysts.

Stock in the Spotlight: Boston Scientific Corporation (NYSE:BSX)

Boston Scientific Corporation (NYSE:BSX) share price soared 0.08% or 0.02 points to reach at $23.90 during previous trading session. The stock’s price fluctuated within the range of $23.60 – $24.04 during previous trading session. A total of 8.58M shares exchanged hands, whereas the company’s average trading volume stands at 7.63M shares. Boston Scientific Corporation (NYSE:BSX) has a market capitalization of $32.57B and most recently 1.36B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Boston Scientific Corporation (NYSE:BSX) is at 76.50.

According to sentiments of 21 analysts the mean estimates of short term price target for the company’s stock is marked at $27.38. The most optimistic analyst sees the stock reaching $30 while the most conventional predicts the target price at $24.

The consensus mean EPS for the current quarter is at $0.29 derived from a total of 24 estimates. According to analysts minimum EPS for the current quarter is expected at $0.28 and can go high up to $0.3. However a year ago during same quarter Sarepta Therapeutics Inc (NASDAQ:SRPT) reported $0.26 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.29 per share according to consensus of 18 analysts.

According to sentiments of 21 analysts the company is expected to report revenues of $2.16B for the current quarter. Bearish revenue estimates established at $2.14B while the bullish revenue forecast has been figured out at $2.19B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 1.80 on the shares of Boston Scientific Corporation (NYSE:BSX). Out of rating recommendations 10 have given the stock a Buy while 10 recommend the stock as Outperform. 5 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Boston Scientific Corporation (NYSE:BSX)’s distance from 20 day simple moving average is 6.34% whereas its distance from 50 day simple moving average is 10.30% along with 6.11% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Boston Scientific Corporation (NYSE:BSX) shares were trading -3.59% below from the 52-week high mark of $24.79 and +52.52% above from the 52-week bottom of $15.67. The stock hit its 52-week high price on 7/28/16 and 52-week low price on 2/8/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 1.62% in the past one week and soared 11.32% during previous one month drive, the stock went up 4.50% during past quarter. In the last six months the stock’s performance fell -0.08% while yearly performance of the company advanced 36.10%.The company’s year to date (YTD) performance is at 10.49%.

While taking a glance at financials, we can look at a number of key indicators. Boston Scientific Corporation (NYSE:BSX) has a Return on Assets (ROA) of 0.50%. The company currently has a Return on Equity (ROE) of 1.30% and a Return on Investment (ROI) of 0.70%. Average true range (ATR-14) of the company sets at 0.38, along with its weekly and monthly volatility of 1.40%, 1.62% respectively. Beta value of the stock stands at 1.06.

The company’s price to free cash flow for trailing twelve months is 117.39. Its quick ratio for most recent quarter is 0.70 along with current ratio for most recent quarter of 1.00. Total debt to equity ratio of the company for most recent quarter is 0.84 whereas long term debt to equity ratio for most recent quarter is 0.80.

Featured Stock: Boston Scientific Corporation (NYSE:BSX)

Boston Scientific Corporation (NYSE:BSX) share price soared 1.28 % or +0.30 points to reach at $23.82 during previous trading session. The stock’s price fluctuated within the range of $23.45 – $23.91 during previous trading session. A total of 9,485,500 shares exchanged hands, whereas the company’s average trading volume stands at 8.79M shares. Boston Scientific Corporation (NYSE:BSX) has a market capitalization of $32.85B and most recently 1.36B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Boston Scientific Corporation (NYSE:BSX) is at 78.16.

According to sentiments of 22 analysts the mean estimates of short term price target for the company’s stock is marked at $27.55. The most optimistic analyst sees the stock reaching $31.00 while the most conventional predicts the target price at $24.00.

The consensus mean EPS for the current quarter is at $0.29 derived from a total of 25 estimates. According to analysts minimum EPS for the current quarter is expected at $0.28 and can go high up to $0.3. However a year ago during same quarter Boston Scientific Corporation (NYSE:BSX) reported $0.26 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.29 per share according to consensus of 19 analysts.

According to sentiments of 22 analysts the company is expected to report revenues of $2.16B for the current quarter. Bearish revenue estimates established at $2.14B while the bullish revenue forecast has been figured out at $2.19B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 1.77 on the shares of Boston Scientific Corporation (NYSE:BSX). Out of rating recommendations 11 have given the stock a Buy while 10 recommend the stock as Outperform. 5 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Boston Scientific Corporation (NYSE:BSX)’s distance from 20 day simple moving average is 8.44% whereas its distance from 50 day simple moving average is 10.86% along with 6.21% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Boston Scientific Corporation (NYSE:BSX) shares were trading -3.91% below from the 52-week high mark of $24.79 and +52.01% above from the 52-week bottom of $15.67. The stock hit its 52-week high price on 07/28/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 7.54% in the past one week and soared 11.62% during previous one month drive, the stock went up 2.89% during past quarter. In the last six months the stock’s performance soared 1.02% while yearly performance of the company advanced 31.17%. The company’s year to date (YTD) performance is at 10.12%.

While taking a glance at financials, we can look at a number of key indicators. Boston Scientific Corporation (NYSE:BSX) has a Return on Assets (ROA) of 0.50%. The company currently has a Return on Equity (ROE) of 1.30% and a Return on Investment (ROI) of 0.70%. Average true range (ATR-14) of the company sets at 0.41, along with its weekly and monthly volatility of 3.03%, 1.65% respectively. Beta value of the stock stands at 1.07.

The company’s price to free cash flow for trailing twelve months is 117.00. Its quick ratio for most recent quarter is 0.70 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.84 whereas long term debt to equity ratio for most recent quarter is 0.80.

A Look at Insider Trading: Boston Scientific Corporation (NYSE:BSX)

Boston Scientific Corporation (NYSE:BSX) exchanged hands 24,092,500 shares versus average trading capacity of 8.81M shares, while its relative trading volume is 2.84. Boston Scientific Corporation (NYSE:BSX)’s total market worth is $34.21B along with 1.36B outstanding shares.

Insiders has most recently took part in a trading activity, Pierce David A, SVP and President, Endoscopy of the company in a transaction that occurred 1/9/2017 sold 10,232 shares of the stock. The stock was sold at a price of $22.24, for a total value of $227,546. Subsequent to the transaction Pierce David A owned a total of 25,600 shares of the stock.

In a separate transaction on 1/9/2017, Pratt Timothy A., EVP, GC & Chief Admin Officer sold 6,195 shares of the stock. The stock was sold at a price of $22.24, for a total worth of $137,769. Succeeding to the transaction Pratt Timothy A. owned overall 231,273 shares of the stock.

Moreover, Fitzgerald Joseph Michael, EVP & President, CRM sold 8,454 shares of the stock in a reserved transaction that ensued on 1/1/2017. At a price of $21.63, the stock was sold for an entire value of $182,860. Consequent to the transaction Fitzgerald Joseph Michael owned a total of 99,612 shares of the stock.

Currently, 0.20% shares of Boston Scientific Corporation (NYSE:BSX) are owned by insiders with -10.04% six-month change in the insider ownership. The insider filler data counts the number of monthly positions over 3 month and 12 month time spans. For Boston Scientific Corporation (NYSE:BSX) total 23 number of trades held during last 3 months and 160 during last 12 months, out of them 0 numbers of buys held in last 3 months and 24 buys in last 12 months. Whereas 23 numbers of sells held in last 3 months and 136 sells over the past 12 months.

For the duration of last three months Boston Scientific Corporation (NYSE:BSX)’s total number of shares bought are 0 and sold 369,753 from a total of 369,753 traded shares. During last twelve months 1,194,874 number of shares bought and 2,589,132 sold from a total of 3,784,006 shares traded. A net activity of 369,753 took place in the course of three months, while 1,394,258 during last twelve months. Insider trading information is derived from Forms 3 and 4 filings are filed with the U.S. Securities and Exchange Commission (SEC).

Boston Scientific Corporation (NYSE:BSX) ended last trading session at the price of $23.61 whereas a number of traders indicating mean target price will hit $27.55 over the next twelve months, mean value of price target most recently revised on 01/10/17. Boston Scientific Corporation (NYSE:BSX)’s highest estimates of price target are $31.00 and low forecast is $24.00 based on the opinion of 22 analysts. The price target estimates represents a standard deviation of 2.53. However brokerage recommendations suggests an ABR of 1.57 based on calls of 22 experts.

Boston Scientific Corporation (NYSE:BSX) is expected to release the earnings of its current quarter on 2/2/17 Before Market Open. The company is expected to release $0.29 EPS during current quarter according to 25 analysts whereas the company reported $0.26 EPS during same quarter a year ago. For the current quarter the stock has a lowest EPS estimates of $0.28 and high estimate of $0.3. Boston Scientific Corporation (NYSE:BSX)’s average revenue estimates for the current quarter are $0.3 according to 22 number of analysts. However its lowest revenue estimates are $2.14B and highest revenue estimates are $2.19B. A year ago the company’s sales were $1.98B. Its yearly sales growth estimates are 9.30%. Past 5 years growth of Boston Scientific Corporation (NYSE:BSX) observed at 30.57%, and for the next five years the analysts that follow this company are expecting its growth at 12.44%.

Analyst Outlook on Price Target: Boston Scientific Corporation (NYSE:BSX)

Boston Scientific Corporation (NYSE:BSX) soared 0.91% during previous trade, a total of 6.46M shares exchanged hands compared with its average trading volume of 7.77M shares whereas its relative volume is 0.76. The stock has a market capitalization of $30.41B along with 1.36B outstanding shares. Stock’s intraday price range hit the peak level of $22.10 and touched the lowest level of $21.78.

Most recently Boston Scientific Corporation (NYSE:BSX)’s price target was revised on 01/03/17 and according to 22 analysts stock’s price will reach at $27.66 during 52 weeks with standard deviation of 2.53. Stock’s minimum price target estimates has been figured out at $24 while the maximum price target forecast is established at $31, if we look at the price target with an optimistic approach it has upside potential of 42% from its latest closing price of $22.08.

Historically, if we look at price target revisions, three weeks ago Boston Scientific Corporation (NYSE:BSX)’s price target was revised on 11/15/16 by the analysts, however the bullish price estimates of the stock set at $30 while the bearish estimates kept at $19.50 over the next one year. Stock’s 52-week target was retained at $26.64, the estimates indicates a standard deviation of 2.53.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 1.57. ABR value is precisely based on brokerage recommendations, where out of 22 brokerage recommendations 14 rate Boston Scientific Corporation (NYSE:BSX) stock a Strong Buy, 3 rate the stocks of the company a Buy, 5 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 9/1/2016 the stock of Boston Scientific Corporation (NYSE:BSX) upgraded by Argus from Hold to Buy. However previously on 10/5/15 it was upgraded by Raymond James from Outperform to Strong Buy. A research note issued on 9/28/15 the stock was upgraded by Needham from Hold to Buy.

Boston Scientific Corporation (NYSE:BSX) performance over the past one year soared 21.45% whereas its year to date (YTD) performance indicated a bullish trend of 2.08%. During the last six months the stock slipped -6.72%. Quarterly performance of the company shows declining momentum of -5.15% while its last one month trend is positive with 8.50%. Stock’s weekly performance expressed up trend of 1.47%.

The company’s price sits 3.05% above from its 50-day moving average of $21.17 and -0.86% away from the stock’s 200-day moving average which is $22.83. Boston Scientific Corporation (NYSE:BSX)’s shares are currently trading -10.93% away from the 52-week high price of $24.79 and +40.91% far from the 52-week low price of $15.67.

According to consensus agreement of 25 analysts Boston Scientific Corporation (NYSE:BSX) will report earnings per share of $0.29 in their quarterly report and it is expected to announce the company’s results on 2/2/17. For the current quarter the company has high EPS estimates of $0.3 in contradiction of low EPS estimates of $0.28. However a year ago for the same quarter the company has reported $0.26 EPS. Current year EPS projections for Boston Scientific Corporation (NYSE:BSX) set at $1.1 according to the sentiments of 27 analysts, while its lowest earnings estimates are $1.09 and highest earnings estimates are $1.12.

According to 22 analysts, Boston Scientific Corporation (NYSE:BSX)’s revenue estimates for the current quarter are $2.16B meanwhile the company has high revenue estimates of $2.19B in contradiction of low revenue estimates of $2.14B. For the current year the company’s revenue estimates are $8.36B compared to low analyst estimates of $8.34B and high estimates of $8.38B according to the projection of 25 analysts.